Curaleaf Holdings Inc (CURLF) is a publicly traded drug manufacturers - specialty and generic business based in the US which employs around 5,650 staff. Curaleaf Holdings is listed on the OTCQX (a marketplace for buying and selling "over the counter" stocks which aren't listed on a formal stock exchange) and traded in US dollars. Its current price of $5.02 is 0.6% down on its price a month ago ($5.05).
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Curaleaf Holdings), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Curaleaf Holdings is a major part of the OTCQX, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
April 7, 2024: Cannabis grower Curaleaf is considering a secondary European market listing after the drug became legal in Germany. Reports say Frankfurt and London are the top exchanges being considered.
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Over the last 12 months, Curaleaf Holdings's shares have ranged in value from as little as $2.19 up to $5.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQX average) beta is 1, while Curaleaf Holdings's is 1.596. This would suggest that Curaleaf Holdings's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Historical closes compared with the last close of $5.02
| 1 week (2024-04-18) | 1.62% |
|---|---|
| 1 month (2024-03-25) | -0.59% |
| 3 months (2024-01-25) | -1.76% |
| 6 months (2023-10-25) | 65.13% |
| 1 year (2023-04-25) | 110.04% |
| 3 years (2021-04-25) | -61.91% |
| 5 years (2019-04-25) | -51.08% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Curaleaf Holdings P/E ratio, PEG ratio and EBITDA
Curaleaf Holdings's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $238.8 million (£191 million).
The EBITDA is a measure of a Curaleaf Holdings's overall financial performance and is widely used to measure a its profitability.
Sign up for weekly expert share tips
Join 100,000 subscribers who are notified about expert share tips. Plus a chance to win £800!
By signing up you agree to receive emails from Finder and to the privacy policy and terms & conditions.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.
Ever wondered how to buy shares in Green Thumb Industries? We explain how and compare a range of providers that can give you access to many brands, including Green Thumb Industries.
Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.
Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.
Ever wondered how to buy shares in 4D pharma? We explain how and compare a range of providers that can give you access to many brands, including 4D pharma.
Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.
Thinking about buying shares in Evgen Pharma? We explain how to do it and compare a range of providers who will give you access to global markets.
Ever wondered how to buy shares in Intuitive Surgical? We explain how and compare a range of providers that can give you access to many brands, including Intuitive Surgical.
Ever wondered how to buy shares in Stryker? We explain how and compare a range of providers that can give you access to many brands, including Stryker.